Records FDA files under its code for over-the-counter radiofrequency wrinkle devices: handheld devices that heat the skin with radiofrequency energy.
12 records from 2015 to 2026, filed by 5 companies, including 1 De Novo grant (DEN150005). We quote the indications for use for 5 of them from FDA's PDFs.
What FDA's code PAY covers
FDA device name
“Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction”
FDA definition
“An electrosurgical device for over-the-counter aesthetic use is a device using radiofrequency energy to produce localized heating within tissues for non-invasive aesthetic use.”
Physical state
“Radiofrequency current generator and electrode applicators”
Technical method
“Radiofrequency electrical current (i.e., electrosurgical device)”
Target area
“skin wrinkles and rhytides”
Regulation
21 CFR 878.4420: “An electrosurgical device for over-the-counter aesthetic use is a device using radiofrequency energy to produce localized heating within tissues for non-invasive aesthetic use.”
The regulation for this code requires the labeling to carry “A statement that the safety and effectiveness of the device's use for uses other than the indicated aesthetic use are not known.” (21 CFR 878.4420).
All 12 records, newest first
Each record is one FDA decision about the device named in it, for the use in its indications statement. The company that filed may be the brand on the box or the manufacturer that makes it for the brand.
Records are grouped by FDA product code; a record's own indications can be narrower, broader or different from the group name, so read each one. We quote an indications statement only when it comes from a text page of FDA's PDF (not a scan) and every word checks out; otherwise the entry says why and links the PDF, which is the authority.
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
Substantially Equivalent (SESE)
Received
Indications for use
Not quoted here. The page with this statement is a scanned image whose text was machine-read, so we can't vouch for it word for word. Read FDA's PDF, page 4.
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
Substantially Equivalent (SESE)
Received
Indications for use, as filed
“The CurrentBody Skin RF (ST030) device is an over-the-counter home-use device intended for non-invasive treatment of mild to moderate facial wrinkles for adults with Fitzpatrick skin types I-IV.”
Source discrepancy: this statement names “ST030”, which doesn't appear in the device name in FDA's database. Both are shown exactly as FDA's records have them.
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
Substantially Equivalent (SESE)
Received
Indications for use, as filed
“The Silk’n Titan AllWays is an over-the-counter home use device intended for the non-invasive treatment of mild to moderate facial wrinkles for adult women who have Fitzpatrick skin types I-IV.”
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
Substantially Equivalent (SESE)
Received
Indications for use, as filed
“The STOP U Model UXV device is intended for use in the non-invasive treatment of mild to moderate facial wrinkles for adult users who have Fitzpatrick Skin Types I-IV.”
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
Substantially Equivalent (SESE)
Received
Indications for use, as filed
“The STOP U device is intended for use in the non-invasive treatment of mild to moderate facial wrinkles for adult users who have Fitzpatrick Skin Types II-IV.”
PAY: Over-The-Counter Radiofrequency Coagulation Device For Wrinkle Reduction
Regulation
21 CFR 878.4420, Class II
FDA decision
De Novo request granted
Received
Indications for use, as filed
“The EndyMed Newa™ is an over-the-counter home use device intended for non-invasive treatment of mild to moderate facial wrinkles for adult women who have Fitzpatrick Skin Types I-IV.”